- Home
- PWM vs ATHA Comparison
PWM vs ATHA Comparison
Compare PWM & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWM
- ATHA
- Stock Information
- Founded
- PWM 2018
- ATHA 2011
- Country
- PWM Hong Kong
- ATHA United States
- Employees
- PWM N/A
- ATHA N/A
- Industry
- PWM
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- PWM
- ATHA Health Care
- Exchange
- PWM Nasdaq
- ATHA Nasdaq
- Market Cap
- PWM 12.4M
- ATHA 14.8M
- IPO Year
- PWM 2023
- ATHA 2020
- Fundamental
- Price
- PWM $0.53
- ATHA $0.38
- Analyst Decision
- PWM
- ATHA Hold
- Analyst Count
- PWM 0
- ATHA 1
- Target Price
- PWM N/A
- ATHA $0.50
- AVG Volume (30 Days)
- PWM 1.2M
- ATHA 170.5K
- Earning Date
- PWM 02-13-2026
- ATHA 11-06-2025
- Dividend Yield
- PWM N/A
- ATHA N/A
- EPS Growth
- PWM N/A
- ATHA N/A
- EPS
- PWM N/A
- ATHA N/A
- Revenue
- PWM $639,912.00
- ATHA N/A
- Revenue This Year
- PWM N/A
- ATHA N/A
- Revenue Next Year
- PWM N/A
- ATHA N/A
- P/E Ratio
- PWM N/A
- ATHA N/A
- Revenue Growth
- PWM 83.60
- ATHA N/A
- 52 Week Low
- PWM $0.31
- ATHA $0.22
- 52 Week High
- PWM $2.70
- ATHA $0.83
- Technical
- Relative Strength Index (RSI)
- PWM 54.53
- ATHA 51.37
- Support Level
- PWM $0.51
- ATHA N/A
- Resistance Level
- PWM $0.58
- ATHA $0.40
- Average True Range (ATR)
- PWM 0.05
- ATHA 0.02
- MACD
- PWM -0.01
- ATHA -0.02
- Stochastic Oscillator
- PWM 24.34
- ATHA 93.55
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.